Triple-negative breast cancer molecular subtyping and treatment progress | Breast Cancer Research | Full Text

Triple-negative breast cancer molecular subtyping and treatment progress | Breast Cancer Research | Full Text

Triple-negative breast cancer molecular subtyping and treatment progress

Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2), has clin...

Authors:Li Yin, Jiang-Jie Duan, Xiu-Wu Bian and Shi-cang Yu

Citation:Breast Cancer Research 2020 22:61

Content type:Review

 

Published on: 9 June 2020

• ViewFull Text
 
• ViewPDF